전남대학교 중앙도서관

Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.

학술저널

issue: The Journal of clinical investigation [J Clin Invest] 2024 Jan 09; Vol. 134 (6). Date of Electronic Publication: 2024 Jan 09.
Author: Jongo S; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Church LWP; Sanaria Inc., Rockville, Maryland, USA.
Milando F; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Qassim M; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Schindler T; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Rashid M; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Tumbo A; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Nyaulingo G; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Bakari BM; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Athuman Mbaga T; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Mohamed L; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Kassimu K; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Simon BS; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Mpina M; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Zaidi I; Laboratory of Malaria Immunology and Vaccinology and.
Duffy PE; Laboratory of Malaria Immunology and Vaccinology and.
Swanson PA 2nd; Vaccine Research Center, NIH, Bethesda, Maryland, USA.
Seder R; Vaccine Research Center, NIH, Bethesda, Maryland, USA.
Herman JD; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Mendu M; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Zur Y; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Alter G; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Kc N; Sanaria Inc., Rockville, Maryland, USA.; Protein Potential LLC, Rockville, Maryland, USA.
Riyahi P; Sanaria Inc., Rockville, Maryland, USA.
Abebe Y; Sanaria Inc., Rockville, Maryland, USA.
Murshedkar T; Sanaria Inc., Rockville, Maryland, USA.
James ER; Sanaria Inc., Rockville, Maryland, USA.
Billingsley PF; Sanaria Inc., Rockville, Maryland, USA.
Sim BKL; Sanaria Inc., Rockville, Maryland, USA.; Protein Potential LLC, Rockville, Maryland, USA.
Richie TL; Sanaria Inc., Rockville, Maryland, USA.
Daubenberger C; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Abdulla S; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Hoffman SL; Sanaria Inc., Rockville, Maryland, USA.
DB Label: Database : MEDLINE

원문보기: Open Access (PubMed Central) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.

학술저널

issue: Med (New York, N.Y.) [Med] 2023 Oct 13; Vol. 4 (10), pp. 668-686.e7. Date of Electronic Publication: 2023 Aug 11.
Author: Silk SE; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Kalinga WF; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Mtaka IM; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Lilolime NS; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Mpina M; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Milando F; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Ahmed S; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Diouf A; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA.
Mkwepu F; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Simon B; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Athumani T; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Rashid M; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Mohammed L; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Lweno O; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Ali AM; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Nyaulingo G; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Mwalimu B; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Mswata S; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Mwamlima TG; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Barrett JR; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Wang LT; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Themistocleous Y; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK.
King LDW; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Hodgson SH; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Payne RO; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK.
Nielsen CM; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Lawrie AM; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK.
Nugent FL; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK.
Cho JS; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK.
Long CA; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA.
Miura K; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA.
Draper SJ; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Minassian AM; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: angela.minassian@bioch.ox.ac.uk.
Olotu AI; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
DB Label: Database : MEDLINE

원문보기: 등재 - SCOPUS

Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania.

학술저널

issue: Tropical medicine and infectious disease [Trop Med Infect Dis] 2022 Nov 25; Vol. 7 (12). Date of Electronic Publication: 2022 Nov 25.
Author: Kassimu K; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.; Department of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.
Milando F; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Omolo J; Department of Traditional Medicine, National Institute for Medical Research, Dar es Salaam P.O. Box 9653, Tanzania.
Mdemu A; Department of Traditional Medicine, National Institute for Medical Research, Dar es Salaam P.O. Box 9653, Tanzania.
Nyaulingo G; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Mbarak H; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Mohamed L; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Rashid R; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Ahmed S; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Rashid M; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Msami H; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Damiano D; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Simon B; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Mbaga T; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Issa F; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Lweno O; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Balige N; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Hassan O; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Mwalimu B; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Hamad A; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Olotu A; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Mårtensson A; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, S-751 85 Uppsala, Sweden.
Machumi F; Institute of Traditional Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.
Jongo S; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
Ngasala B; Department of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania.; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, S-751 85 Uppsala, Sweden.
Abdulla S; Bagamoyo Clinical Trial Facility, Ifakara Health Institute, Bagamoyo P.O. Box 74, Tanzania.
DB Label: Database : MEDLINE

원문보기: Open Access (PubMed Central) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Motivations and barriers for healthy participants to participate in herbal remedy clinical trial in Tanzania: A qualitative study based on the theory of planned behaviour.

학술저널